Literature DB >> 12466511

Clinical practice. Latent tuberculosis infection.

Robert M Jasmer1, Payam Nahid, Philip C Hopewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12466511     DOI： 10.1056/NEJMcp021045

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  100 in total

1.  Isolated tuberculosis of tunica vaginalis in a child.

Authors:  Paiboon Sookpotarom; Kullathida Nimanussornkul; Orawin Luecha; Rapol Poolsavatkitikool; Paisarn Vejchapipat
Journal:  Pediatr Surg Int       Date:  2010-04-28       Impact factor: 1.827

2.  Low yield of chest radiography in a large tuberculosis screening program.

Authors:  Ronald L Eisenberg; Nira R Pollock
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

3.  Molecular Interaction of Novel Compound 2-Methylheptyl Isonicotinate Produced by Streptomyces sp. 201 with Dihydrodipicolinate Synthase (DHDPS) Enzyme of Mycobacterium tuberculosis for its Antibacterial Activity.

Authors:  Salam Pradeep Singh; T C Bora; R L Bezbaruah
Journal:  Indian J Microbiol       Date:  2012-02-05       Impact factor: 2.461

4.  Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Authors:  Sonia Mínguez; Irene Latorre; Lourdes Mateo; Alicia Lacoma; Jéssica Diaz; Alejandro Olivé; Jose Domínguez
Journal:  Clin Rheumatol       Date:  2012-01-21       Impact factor: 2.980

5.  An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.

Authors:  Luigi Codecasa; Paola Mantegani; Laura Galli; Adriano Lazzarin; Paolo Scarpellini; Claudio Fortis
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

6.  Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice.

Authors:  T Meier; H-P Eulenbruch; P Wrighton-Smith; G Enders; T Regnath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

7.  Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis.

Authors:  Liliana Encinales; Joaquin Zuñiga; Julio Granados-Montiel; Maria Yunis; Julio Granados; Ingrid Almeciga; Olga Clavijo; Carlos Awad; Vilma Collazos; María Inés Vargas-Rojas; José Luis Bañales-Mendez; Lilia Vazquez-Castañeda; Joel N Stern; Viviana Romero; Masha Fridkis-Hareli; Masha Frindkis-Hareli; Daniel Terreros; Marcelo Fernandez-Viña; Edmond J Yunis
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

Review 8.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

9.  Solution structures of Mycobacterium tuberculosis thioredoxin C and models of intact thioredoxin system suggest new approaches to inhibitor and drug design.

Authors:  Andrew L Olson; Terrence S Neumann; Sheng Cai; Daniel S Sem
Journal:  Proteins       Date:  2013-01-15

10.  Tuberculosis incidence among contacts of active pulmonary tuberculosis.

Authors:  M Cailleaux-Cezar; D de A Melo; G M Xavier; C L G de Salles; F C Q de Mello; A Ruffino-Netto; J E Golub; A Efron; R E Chaisson; M B Conde
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.